Dr Adie Poe

Postdoctoral Research Associate
Kolling Institute of Medical Research, Northern Clinical School

Telephone +61 2

Map

Biographical details

My academic and research experience have provided me with a diverse background in the fields of psychology, behavioral pharmacology, neuroanatomy, and in vitro physiology. I strive to meaningfully contribute to human health through the development of novel pain therapies, and the training of future scientists.

Research interests

My current research interests include the cellular and molecular mechanisms of opioid/cannabinoid drug interactions, and the cellular adaptations that occur during opioid tolerance.

Teaching and supervision

Neuropharmacology, Neurophysiology

Current projects

  • Cannabinoid modulation of pain relief in during opioid tolerance
  • Adaptations to synaptic transmission during opioid tolerance

Associations

  • Australian Course in Advanced Neuroscience
  • International Narcotics Research Conference

Awards and honours

National ResearchNational Research Service Award
National Institute on Drug Abuse (NIDA), National Institues of Health (NIH):Cannabinoid modulation of neurotransmission during morphine tolerance (1F32 DA034464). Wilson-Poe, A. (Principal Investigator). July 2013 to June 2015.

- Invited conference presentation: International Narcotics Research Conference, July 2013

-Beryl and Jack Jacobs Australasian Travel Award, Royal North Shore Hospital, February 2013

- Alcohol and Drug Abuse Undergraduate Research Fellowship, Washington State University, April 2005Service Award
National Institute on Drug Abuse (NIDA), National Institues of Health (NIH)
June 2013
Project Title: Cannabinoid modulation of neurotransmission during morphine tolerance (1F32 DA034464). Wilson-Poe, A. (Principal Investigator). June 2013 to May 2015. $87,000 direct costs.
Australian Course in Advanced Neuroscience (ACAN)
Australian Neuroscience Society
January 2013
ACAN is the pre-eminent course in the Asia-Pacific region for young scientists becoming experts in cellular neurophysiology. ACAN delivers an intensive, 3-week learning experience. Leading Australian and overseas experts work with small groups of students to provide rigorous training in the theory and practice of neurophysiology and fluorescence imaging. Accepted to course in January 2013, for attendance April 14 - May 4, 2013.
NIH Grant: Neural Mechanisms of Enhanced Cannabinoid/Opioid Antinociception (R03 DA026591)
National Institute on Drug Abuse
May 2009
Morgan, M. M. (Wilson, A. R., Co-author and Key Personnel). May, 2009 to April, 2011. $100,000 direct costs. Resulted in three first-author publications.
Additional Honors & Awards
- Invited conference presentation: International Narcotics Research Conference, July 2013
- Beryl and Jack Jacobs Australasian Travel Award, Royal North Shore Hospital, February 2013
- Alcohol and Drug Abuse Undergraduate Research Fellowship, Washington State University, April 2005

Selected grants

2013

  • Cannabinoid modulation of neurotransmission during morphine tolerance; Poe A; National Institutes of Health (USA)/Research Support.

To update your profile click here. For support on your academic profile contact .